?

Alerts & Discovery

What the AI noticed today

Personalized alerts, a daily discovery feed, and your notification settings.

AI-generated estimates only. Not financial advice. Market conditions can change and no outcome is guaranteed.

Emerging Stock2h ago
PLTRPalantir Technologies

Palantir (PLTR) gaining analyst attention on AI platform wins

Why surfaced: Three analysts raised price targets after enterprise AIP customer wins.

Why investors are watching: AI software adoption is moving from pilots into committed multi-year contracts.

Why it may have potential: Could continue to compound as more enterprises standardize on its AI platform.

What the risks are: Already trades at a premium — disappointment could trigger a sharp pullback.

Educational signal — not financial advice. Markets and conditions change.

Affordable Entry4h ago
SMRNuScale Power

NuScale Power (SMR) showing improving momentum on nuclear demand

Why surfaced: Volume up 3x its 30-day average on hyperscaler nuclear-deal headlines.

Why investors are watching: AI data centers are reigniting demand for clean baseload power.

Why it may have potential: Small modular reactors could become a strategic energy category this decade.

What the risks are: Pre-commercial business — meaningful revenue is still years out.

Educational signal — not financial advice. Markets and conditions change.

Crypto Momentum5h ago
RNDRRender NetworkCrypto

Render (RNDR) seeing rising adoption alongside AI compute demand

Why surfaced: Render network usage hit a new monthly high alongside rising AI compute demand.

Why investors are watching: Decentralized GPU networks could benefit as AI compute stays scarce.

Why it may have potential: Sits at the crossroads of AI and crypto narratives, attracting both audiences.

What the risks are: Highly speculative — narrative trades can reverse just as fast as they rise.

Educational signal — not financial advice. Markets and conditions change.

Affordable Entry7h ago
SOFISoFi Technologies

SoFi (SOFI) reaches a new profitability milestone

Why surfaced: Quarterly earnings showed accelerating member growth and improving margins.

Why investors are watching: Younger consumers are continuing to migrate from legacy banks.

Why it may have potential: Could re-rate higher if profitability trend continues for several quarters.

What the risks are: Sensitive to credit cycles — recession could increase loan losses.

Educational signal — not financial advice. Markets and conditions change.

Adoption Signal9h ago
ETHEthereumCrypto

Ethereum (ETH) sees record Layer-2 transaction volume

Why surfaced: Cumulative L2 activity hit an all-time high as fees dropped further.

Why investors are watching: Cheaper transactions make Ethereum apps usable for everyday users.

Why it may have potential: Long-term thesis around ETH as base settlement layer continues to play out.

What the risks are: Activity does not always translate immediately into price.

Educational signal — not financial advice. Markets and conditions change.

Institutional Flow11h ago
RKLBRocket Lab USA

Rocket Lab (RKLB) flagged on institutional accumulation

Why surfaced: 13F filings show several funds adding to positions over the last quarter.

Why investors are watching: Defense and commercial launch demand is expanding simultaneously.

Why it may have potential: If Neutron rocket succeeds, the addressable market expands significantly.

What the risks are: Test failures or delays could create sharp short-term volatility.

Educational signal — not financial advice. Markets and conditions change.

Crypto Momentum14h ago
SOLSolanaCrypto

Solana (SOL) network activity hits a new high

Why surfaced: Daily active addresses and DEX volume both reached year-to-date records.

Why investors are watching: Consumer crypto apps continue to favor Solana for speed and low fees.

Why it may have potential: Sustained user growth could broaden institutional product offerings.

What the risks are: Higher volatility — drawdowns can be steep during risk-off periods.

Educational signal — not financial advice. Markets and conditions change.

Analyst Sentiment18h ago
CRSPCRISPR Therapeutics

CRISPR Therapeutics (CRSP) upgraded on faster therapy uptake

Why surfaced: Two firms raised ratings on improving early commercial data.

Why investors are watching: Gene editing is a brand-new therapy category just starting to scale.

Why it may have potential: Successful uptake validates the broader CRISPR platform.

What the risks are: Reimbursement and access challenges remain real headwinds.

Educational signal — not financial advice. Markets and conditions change.